Half-year summary of NATUREX's
liquidity contract with EXANE BNP PARIBAS
Press release
Avignon, 11 January 2016
Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of December 31, 2015, negotiation date:
- 4,438 NATUREX shares
- 562,790.00 euros
It is reminded that the following assets appeared on the liquidity account as of June 30, 2015, negotiation date:
- 3,970 NATUREX shares
- 558,930.00 euros
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
-
Financial schedule
Revenue – FY 2015 04 February 2016 Results – FY 2015 30 March 2016
-
Upcoming events
SFAF Analysts Meeting 31 March 2016 General Meeting 21 June 2016
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
|
Total number of shares comprising the share capital: 9,238,850 (December 2015)
ISIN FR0000054694 Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,700 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
|
Carole Alexandre
Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour
Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Information réglementée
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-42709-cp_naturex_110116.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer